Home‐Based Testing as an Approach to Estimate Influenza Vaccine Effectiveness in South Africa, 2021–2022—A Pilot Study
Open Access
- 8 December 2024
- journal article
- research article
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 18 (12) , e70034
Abstract
Background: Surveillance programmes for influenza and other respiratory pathogens are important to generate vaccine effectiveness (VE) estimates and to inform vaccine composition. We aimed to explore the feasibility and acceptability of home‐based testing.Methods: In three out of nine provinces in South Africa, we established a self‐referral system for individuals aged ≥ 18 years with respiratory symptoms of ≤ 10 days duration. Following consent, swab collection material was delivered to participants who also completed a questionnaire including self‐reported vaccination status. Swabs were tested by PCR for influenza, respiratory syncytial virus (RSV) and SARS‐CoV‐2. A test‐negative methodology was used to estimate influenza VE.Results: Of 1456 samples collected between 19 November 2021 and 3 September 2022, 73 (5%) tested positive for influenza, 38 (3%) tested positive for RSV and 394 (27%) for SARS‐CoV‐2. We subtyped 55% (40/73) of the influenza positive specimens; 16/40 (40%) were influenza A(H1N1)pdm09; 10/40 (25%)A(H3N2)) and all 14/40(35%) influenza B were B/Victoria. Only 20% (279/1451) of participants reported influenza‐like illness case definition symptoms of fever and cough. Influenza vaccine coverage was 11% (157/1454). The overall influenza VE was 26% (95% confidence interval: −73%, 69%). Of the completed acceptability questionnaires, 123/127 (97%) participants would make use of the service again; 90% (1306) were recruited via the COVID‐19 testing centre (call in, social media, webpage), and 7% (99/1306) through CoughWatchSA.Conclusions: Home‐based swabbing was feasible and acceptable. We were able to calculate an influenza VE, although a larger sample size and verification of vaccine status may improve the VE estimates in the future.Keywords
All Related Versions
Funding Information
- Sanofi (FLU00177)
This publication has 5 references indexed in Scilit:
- Patient and stakeholder perspectives on impacts of the COVID-19 pandemic on HIV and mental health care delivery in South AfricaInternational Journal of STD & AIDS, 2023
- A remote household‐based approach to influenza self‐testing and antiviral treatmentInfluenza and Other Respiratory Viruses, 2021
- Health and economic burden of influenza‐associated illness in South Africa, 2013‐2015Influenza and Other Respiratory Viruses, 2019
- Equivalence of Self- and Staff-Collected Nasal Swabs for the Detection of Viral Respiratory PathogensPLOS ONE, 2012
- Validation of Self-swab for Virologic Confirmation of Influenza Virus Infections in a Community SettingThe Journal of Infectious Diseases, 2011